Medicamen Biotech Limited (MEDICAMEQ) — Board Meeting | 18 August 2026
Medicamen Biotech announced that its 33rd Annual General Meeting will be held on September 19, 2026, with book closure from September 20 to 26, 2026, to determine final dividend entitlement for FY2025-26.
About Medicamen Biotech Limited (MEDICAMEQ)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when MEDICAMEQ files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track MEDICAMEQ — Free💡 Ask AI about this filing
📊 More MEDICAMEQ filings
- 🔴 Insider Trading — 30 September 2026Medicamen Biotech announced a director's sale of 70,000 equity shares on September 28, 2026, reducin...
- Announcement — 28 September 2026Medicamen Biotech Ltd has closed its insider trading window effective October 1, 2026, until 48 hour...
- 🟡 Board Meeting — 28 September 2026Medicamen Biotech held its 33rd AGM on September 26, 2026, where shareholders approved all eight res...
- 🟡 Board Meeting — 26 September 2026Medicamen Biotech held its 33rd AGM on 26 September 2026 via video conference, adopting audited stan...
- 🔴 Annual Report — 3 September 2026Medicamen Biotech Ltd held its 33rd AGM on September 26, 2026 via video conferencing, approving its ...
🔥 Also filed on 18 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when MEDICAMEQ files new disclosures
Track MEDICAMEQ filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track MEDICAMEQ — FreeFree account · 2 AI queries/day